Clinical and laboratory characteristics of XXXX in @entity1 and adolescents: experience from a medical center.

@entity1 @entity6 @entity1353 @entity1723 @entity1800
BACKGROUND: The incidence of @entity1723 ( @entity1723 ) is increasing rapidly worldwide, predominantly in younger individuals. We developed a checklist of all symptoms of @entity1723 reported in the literature and compared the completeness of the recording of symptoms at initial presentation before and after the checklist was adopted. METHODS: We retrospectively reviewed the records of @entity1 newly diagnosed with @entity1723 from January 1, 1979 through September 30, 2006 to assess the presenting features and test the usefulness of a symptom checklist in evaluating the history on presentation. The checklist was incorporated into the records as of October 1, 1994. RESULTS: Of the 304 @entity1 identified, 130 (43%) had checklists in the charts. There were 146 (48%) @entity1 , 98 (32%) who were diagnosed under the age of 6 years, and 198 (65%) presented with @entity6 ( @entity6 ). Records with a checklist noted @entity6 symptoms that were subtle and easily ignored more often than records without the checklist. As compared with those diagnosed at an older age, @entity1 diagnosed at < or = 6 years were more likely to be male, have @entity6 and a shorter symptom duration, and report more episodes of preceding @entity1800 and @entity1353 . @entity1 with @entity6 also had a shorter symptom duration. CONCLUSIONS: A @entity6 symptom checklist was helpful in identifying clinical @entity6 symptoms and signs which were otherwise easily ignored. Younger @entity1 were more likely to have a shorter symptom duration and a higher incidence of @entity6 .
